Your session is about to expire
← Back to Search
Enhanced Cluster Detection Methods for Outbreak Control (CLUSTER Trial)
N/A
Waitlist Available
Led By Richard Platt, MD, MS
Research Sponsored by Harvard Pilgrim Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess whether an automated, statistically-based cluster detection method can help contain hospital clusters.
Who is the study for?
The CLUSTER Trial is for U.S. HCA Healthcare hospitals providing inpatient care and reporting to a centralized data warehouse during the study period. It's not specified which facilities can't participate, suggesting all eligible ones can join.
What is being tested?
This trial tests an automated statistical method for detecting hospital-associated outbreaks against routine methods. The goal is to see if this new approach helps contain outbreaks faster by reducing their size and duration.
What are the potential side effects?
Since this trial involves institutions rather than individuals, 'side effects' are not applicable in the traditional sense of medical interventions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cluster size
Secondary study objectives
Cluster duration
Other study objectives
Genetic relatedness of clusters of microbial isolates
Pathogen subgroup analysis
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Enhanced cluster detectionActive Control1 Intervention
Hospitals will use an automated statistical cluster detection tool in addition to routine practices for cluster detection with a structured cluster response protocol when a cluster is detected.
Group II: Routine cluster detectionActive Control1 Intervention
Hospitals will use routine practices for cluster detection with a structured cluster response protocol when a cluster is detected.
Find a Location
Who is running the clinical trial?
Centers for Disease Control and PreventionFED
887 Previous Clinical Trials
21,993,375 Total Patients Enrolled
Harvard School of Public Health (HSPH)OTHER
279 Previous Clinical Trials
14,115,268 Total Patients Enrolled
Hospital Corporation of America (HCA) HealthcareUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The clinical trial may only be conducted at certain medical facilities.The study includes all HCA Healthcare hospitals in the United States that admit patients for hospital care.The healthcare facility where you receive treatment must be able to share data with a central database during the study.
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced cluster detection
- Group 2: Routine cluster detection
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger